![Alfonso Quintás-Cardama](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Alfonso Quintás-Cardama currently works at Foghorn Therapeutics, Inc., as Chief Medical Officer from 2023.
Dr. Quintás-Cardama also formerly worked at GSK Plc, as Head-Cell & Gene Therapies Unit, The University of Texas M.D.
Anderson Cancer Center, as Assistant Professor from 2009 to 2014, and TCR² Therapeutics, Inc., as Chief Medical Officer.
Dr. Quintás-Cardama received his doctorate degree from the University of Santiago de Compostela.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 20/04/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| FOGHORN THERAPEUTICS INC. | Director Técnico/Científico/I+D | 11/09/2023 |
| Empresas | Cargo | Fin |
|---|---|---|
The University of Texas M.D. Anderson Cancer Center
 The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Corporate Officer/Principal | 01/01/2014 |
| GSK PLC | Corporate Officer/Principal | - |
| TCR2 THERAPEUTICS INC. | Director Técnico/Científico/I+D | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
The University of Texas M.D. Anderson Cancer Center
The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer | Consumer Services |
University of Santiago de Compostela
 University of Santiago de Compostela Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Foghorn Therapeutics, Inc.
 Foghorn Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops novel drugs to treat cancer and other serious medical disorders | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
